Related Experiment Video
Updated: Mar 18, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Late Relapse After Allogeneic Bone Marrow Transplant In a Patient With Myelodysplasia
S Dunkley1, A Manoharan1, K Atkinson2
1a Department of Haematology , St George Hospital , Sydney , Australia.
Abstract:
Bone Marrow Transplantation remains the only potentially curative procedure for patients with Myelodysplastic syndrome (MDS). Patients who remain disease free 5 years after transplantation have usually been considered cured, but more recent experience challenges this expectation. We report here a case of MDS who relapsed more than 5 years following transplant, and was then successfully treated with a second transplant.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

